Company Filing History:
Years Active: 2018
Title: The Innovations of Stefan Kaulfuß
Introduction
Stefan Kaulfuß is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of diseases.
Latest Patents
One of his key patents is titled "Benzimidazol-2-amines as MIDH1 inhibitors." This invention relates to benzimidazol-2-amines of general formula (I), which are designed to be used in pharmaceutical compositions for the treatment or prophylaxis of diseases, especially neoplasms. The patent outlines methods for preparing these compounds, as well as their potential use in combination with other active ingredients.
Career Highlights
Stefan Kaulfuß is currently employed at Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Hartmut Rehwinkel and Marcus Bauser. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Stefan Kaulfuß is a prominent figure in the field of pharmaceutical innovation, with a patent that showcases his commitment to improving health outcomes. His work continues to influence the development of new treatments for serious diseases.